[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351270-105":59,"doc-detail-351270-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","long-term-infection-risks-in-haematological-cancer-survivors-compared-with-individuals-with-no-cancer-history-protocol-for-a-systematic-review-aided-by-artificial-intelligence-based-methods","Long-term infection risks in haematological cancer survivors compared with individuals with no cancer history - protocol for a systematic review aided by artificial intelligence-based methods","","Infections are a major source of morbidity and mortality in people with haematological cancers, yet the duration of elevated infection risk in long-term survivors is unclear due to the large volume and breadth of existing studies. This protocol outlines a systematic review to determine infection incidence and infection mortality over time in survivors versus general or cancer-free populations, using AI-supported screening. ASReview will prioritise abstracts, with internal validation against manual review. Outcomes will be synthesised narratively when scope is broad; meta-analysis will follow where studies are sufficiently homogeneous, and bias will be assessed with the Newcastle-Ottawa Scale.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/long-term-infection-risks-in-haematological-cancer-survivors-compared-with-individuals-with-no-cancer-history-protocol-for-a-systematic-review-aided-by-artificial-intelligence-based-methods/351270/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/long-term-infection-risks-in-haematological-cancer-survivors-compared-with-individuals-with-no-cancer-history-protocol-for-a-systematic-review-aided-by-artificial-intelligence-based-methods/351270.png","ImageObject",300,407,{"name":92,"@type":93},"\tJames","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main aim of the systematic review protocol?","Question",{"text":112,"@type":113},"To estimate long-term infection incidence and infection mortality in haematological cancer survivors compared with general or cancer-free populations, clarifying how long elevated risk persists.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How will eligible studies be selected and screened?",{"text":117,"@type":113},"Eligible studies are observational and report long-term infection outcomes with at least 1 year follow-up from diagnosis. Screening will be supported by ASReview for abstract prioritisation and validated by comparing AI-assisted results with manual review by two independent researchers.",{"name":119,"@type":110,"acceptedAnswer":120},"How will outcomes and risk of bias be handled in the review?",{"text":121,"@type":113},"Primary outcomes will be summarised by infection type, haematological cancer type, and time since diagnosis. Synthesis will be mainly narrative due to broad scope, with meta-analyses when studies are sufficiently homogeneous, and risk of bias will be assessed using the Newcastle-Ottawa Scale.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351270,1790693044,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":24,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},2336474466412,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Open access Protocol  \nTo cite: Wilson W, Forbes H, Hazell M, et al. Long-term infection risks in haematological cancer survivors compared with individuals with no cancer history: protocol fora systematic review aided by artificial intelligencebased methods. BMJ Open 2026;16:e114803 . doi:10 . 1136/ bmjopen-2025-114803  \n► Prepublication history and additional supplemental material for this paper are available online. To view these files, please visit the journal online ([https://doi.org/10.1136/](https://doi.org/10.1136/)[ ](https://doi.org/10.1136/)[bmjopen-2025-114803](bmjopen-2025-114803)) .  \nReceived 02 December 2025 Accepted 26 February 2026  \n© Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY. Published by BMJ Group. For numbered affiliations see end of article.  \nCorrespondence to  \nWilliam Wilson;  \n[william.wilson1@lshtm.ac.uk](william.wilson1@lshtm.ac.uk)  \nLong-term infection risks in haematological cancer survivors compared with individuals with no cancer history: protocol for a systematic review aided by artificial intelligencebased methods  \nWilliam Wilson  ,1 Harriet Forbes,1 Matthew Hazell,1 Lily Hopkins,1  \nGarth Funston,2 Maeve O’Reilly,3,4 Krishnan Bhaskaran,1 Helena Carreira  1  \nABSTRACT  \nIntroduction Infections are a major cause of morbidity and mortality among individuals with haematological cancers, but the duration of elevated risk in long-term survivors remains uncertain. Although previous attempts to summarise the existing literature on this topic would have been hampered by the sheer volume of studies on cancer and all-cause infections, emerging artificial intelligence tools now offer the ability to streamline the screening process, allowing for broader and more comprehensive reviews.  \nMethods and analysis This protocol follows the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Protocols guidelines. Eligible studies will include original observational data reporting long-term (≥1 year follow-up from diagnosis) infection-related outcomes in haematological cancer survivors compared with a general or cancer-free population. Screening will be supported by ASReview, an artificial intelligence-based tool for abstract prioritisation. An internal validation step will be conducted by comparing artificial intelligence-assisted screening results with manual review performed by two independent researchers on a subset of abstracts. The primary outcomes of infection incidence and infection mortality will be summarised by typeof infection, type of haematological cancer and time since cancer diagnosis. Information on anti-cancer treatments received will also be described. Data synthesis will be mostly narrative due to the broad scope of the review, though meta-analyses will be performed in cases where studies are sufficiently homogenous. Risk of bias will be assessed using the Newcastle-Ottawa Scale.  \nEthics and dissemination Ethical approval is not applicable to this study. The results of the review will be disseminated to clinical audiences and submitted to a peer-reviewed journal. PROSPERO registration number CRD420251047091 .  \nBACKGROUND  \nHaematological malignancies such as leukaemia, lymphoma and multiple myeloma, among others,1 represent a significant burden on public health. Globally, nonHodgkin's lymphoma and leukaemia ranked  \nSTRENGTHS AND LIMITATIONS OF THIS STUDY   \n⇒ Innovative use of artificial intelligence methods with robust internal validation.  \n⇒ Inclusion of all infection types and haematological malignancies provides a comprehensive summary of long-term infection risks across diverse survivor groups.  \n⇒ Searches will be conducted in the two largest and most comprehensive biomedical literature databases (MEDLINE and Embase) with no restrictions on publication date or geography.  \n⇒ Heterogeneity in study populations, outcomes and effect measures may limit comparability and the potential for quantitative synthesis.  \n⇒ Restricting inclusion to Englis","cbCaijARCSr68ZVw","https://ap.wps.com/l/cbCaijARCSr68ZVw","pdf",283291,"English","# Abstract\n# Introduction\n# Methods and analysis\n# Ethics and dissemination\n# Background\n# Strengths and limitations of this study","[{\"question\":\"What is the main aim of the systematic review protocol?\",\"answer\":\"To estimate long-term infection incidence and infection mortality in haematological cancer survivors compared with general or cancer-free populations, clarifying how long elevated risk persists.\"},{\"question\":\"How will eligible studies be selected and screened?\",\"answer\":\"Eligible studies are observational and report long-term infection outcomes with at least 1 year follow-up from diagnosis. Screening will be supported by ASReview for abstract prioritisation and validated by comparing AI-assisted results with manual review by two independent researchers.\"},{\"question\":\"How will outcomes and risk of bias be handled in the review?\",\"answer\":\"Primary outcomes will be summarised by infection type, haematological cancer type, and time since diagnosis. Synthesis will be mainly narrative due to broad scope, with meta-analyses when studies are sufficiently homogeneous, and risk of bias will be assessed using the Newcastle-Ottawa Scale.\"}]","Long-term infection risks in haematological cancer survivors compared with individuals with no cancer history - protocol for a systematic review aided by artificial intelligence-based methods | PDF",1790093293,13,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/09d837ab758e35e877f82602dd43f6fe.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0ac0757688c35bee22904cc32071bd1c.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a8fcf59400a0603b8ac462cc92645c65.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d7798ec4e993193db9dfb118deb926e6.webp",980,1306]